SLC33A1: Acetyl-CoA Transporter and SPG42 Link

Solute Carrier Family 33 Member 1 – Key in Acetylation, Axonal Integrity, and Hereditary Spastic Paraplegia

Gene Information Card

Symbol SLC33A1
Full Name Solute Carrier Family 33 Member 1
Gene Type Protein coding
Chromosomal Location 3q25.31
NCBI Gene ID 9197 ncbi.nlm.nih.gov/gene/9197
Ensembl ID ENSG00000169359
UniProt ID O00400
OMIM ID 603690
HGNC ID 10962
Aliases AT-1, ACATN, SPG42

Description

SLC33A1 encodes the acetyl-CoA transporter 1 (AT-1), a multi-pass transmembrane protein localized to the endoplasmic reticulum and Golgi apparatus. It transports acetyl-CoA from the cytosol into the lumen of these organelles, providing the substrate for N-epsilon-acetylation of proteins, including those involved in axonal maintenance and myelin formation. Loss-of-function mutations in SLC33A1 cause autosomal dominant hereditary spastic paraplegia type 42 (SPG42), characterized by progressive lower limb spasticity and weakness.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hereditary Spastic Paraplegia 42 (SPG42) Dominant-negative or haploinsufficiency of acetyl-CoA transport reduces luminal acetylation, impairing axonal transport and leading to corticospinal tract degeneration. OMIM #612539; multiple missense mutations (e.g., p.Ser113Arg, p.Pro317Leu) reported in families.
Developmental and Epileptic Encephalopathy (DEE) Biallelic loss-of-function variants cause severe neurodevelopmental disorder with seizures, likely due to global acetylation defects. ClinVar; rare homozygous/compound heterozygous variants.

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Liver 8.3 Medium
Kidney 7.1 Medium
Heart 6.4 Low
Lung 5.2 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 15.2 High expression; relevant for neuronal studies
HepG2 (hepatocellular carcinoma) 9.8 Moderate expression
HEK293 (embryonic kidney) 7.5 Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.337A>G (p.Ser113Arg) Missense Unknown Dominant; reduces acetyl-CoA transport; associated with SPG42
c.950C>T (p.Pro317Leu) Missense Unknown Dominant; impairs transporter function; SPG42
c.1A>G (p.Met1?) Start loss Rare Likely loss-of-function; DEE
Mutation functional classification

Loss of Function (LOF)

Biallelic null variants (e.g., start loss, frameshift) cause severe DEE due to complete loss of acetyl-CoA transport.

Gain of Function (GOF)

Not reported for SLC33A1.

Dominant Negative (DN)

Missense mutations (e.g., p.Ser113Arg) act via dominant-negative effect, reducing overall transporter activity in the ER/Golgi.

Gene Ontology (GO)

• GO:0015870 – acetyl-CoA transport • GO:0016021 – integral component of membrane
• GO:0005783 – endoplasmic reticulum • GO:0005794 – Golgi apparatus
• GO:0016740 – transferase activity (acetyl group)

Pathways

Acetyl-CoA transport (Reactome: R-HSA-8873719)
Protein acetylation in ER/Golgi (Reactome: R-HSA-381038)

Protein Summary

The SLC33A1 protein (AT-1) is a 549-amino acid transmembrane transporter with 6-8 predicted membrane-spanning domains. It resides in the ER and Golgi membranes, where it mediates the import of cytosolic acetyl-CoA into the lumen. This acetyl-CoA is used for N-epsilon-acetylation of nascent proteins, a modification critical for proper folding, stability, and function of secreted and membrane proteins. In neurons, AT-1 is essential for axonal integrity; its dysfunction leads to spastic paraplegia.

Related Products

Product name Cat.No. Species Gene ID
SLC33A1 Knockout HEK293 Cell Line EDJ-KQ6493 Human 9197 Details Get a Quote
SLC33A1 Knockout HeLa Cell Line EDJ-KQ29277 Human 9197 Details Get a Quote
SLC33A1 Knockout HCT 116 Cell Line EDC07721 Human 9197 Details Get a Quote
SLC33A1 Knockout A-549 Cell Line EDJ-KQ63583 Human 9197 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: